<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">Studies conducted in recent decades have identified a number of genes and variants associated with PD
 <sup>
  <xref ref-type="bibr" rid="CR4">4</xref>–
  <xref ref-type="bibr" rid="CR12">12</xref>
 </sup>. It is estimated that 5–10% of all PD cases have a genetic etiology linked to forms with monogenic Mendelian inheritance patterns. These forms are attributed to various loci containing genes, such as 
 <italic>SNCA</italic>, 
 <italic>PRKN</italic>, 
 <italic>PARK7</italic>, and 
 <italic>LRRK2</italic> (refs. 
 <sup>
  <xref ref-type="bibr" rid="CR13">13</xref>–
  <xref ref-type="bibr" rid="CR15">15</xref>
 </sup>). In the rest of the cases, called sporadic, genetic susceptibility factors have also been demonstrated. So far, &gt;90 risk loci have been identified; the associated variants are mainly single-nucleotide polymorphisms (SNPs)
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>,
  <xref ref-type="bibr" rid="CR8">8</xref>,
  <xref ref-type="bibr" rid="CR10">10</xref>,
  <xref ref-type="bibr" rid="CR12">12</xref>,
  <xref ref-type="bibr" rid="CR14">14</xref>
 </sup>. Some of these SNPs are located within or very close to loci linked to the familial forms mentioned above, which indicates that changes in the sequence of these genes are likely to be implicated in the key biological processes of PD development
 <sup>
  <xref ref-type="bibr" rid="CR14">14</xref>,
  <xref ref-type="bibr" rid="CR16">16</xref>
 </sup>. The identification and functional characterization of these genetic changes have provided information on the cellular and subcellular mechanisms contributing to PD-related neurodegeneration
 <sup>
  <xref ref-type="bibr" rid="CR15">15</xref>–
  <xref ref-type="bibr" rid="CR21">21</xref>
 </sup>.
</p>
